Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed133%
recruiting267%

Recent Activity

2 active trials
Showing 3 of 3
recruitingnot_applicable

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

NCT06819475
recruiting

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

NCT06089083
completednot_applicable

Evaluation of Physical Functions in Lower Limb Burn Injury

NCT04157504

Clinical Trials (3)

Showing 3 of 3 trials
NCT06819475Not Applicable

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

Recruiting
NCT06089083

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

Recruiting
NCT04157504Not Applicable

Evaluation of Physical Functions in Lower Limb Burn Injury

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3